[Efficacy of heliox therapy in respiratory insufficiency in infants and children]

Area of Science:

• Pediatric Critical Care Medicine
• Respiratory Medicine
• Helium-Oxygen Therapy

Background:

• Airway insufficiency in critically ill infants and children presents significant management challenges.
• Heliox therapy, a mixture of helium and oxygen, is explored for its potential to reduce work of breathing.

Purpose of the Study:

• To evaluate the effectiveness of heliox therapy in critically ill pediatric patients experiencing upper and/or lower airway respiratory insufficiency.
• To assess clinical outcomes and the need for ventilatory support following heliox administration.

Main Methods:

• A study involving 65 pediatric patients (12 days to 8 years) treated with heliox via mask, nasal prongs, or non-invasive ventilation.
• Diagnoses included bronchiolitis, postextubation respiratory insufficiency, post-airway surgery insufficiency, and croup-laryngotracheomalacia.
• Response was measured by clinical scores, respiratory rate, heart rate, pulse oximetry, blood gas analysis, and need for ventilation.

Main Results:

• 83.1% of patients showed improvement, with significant reductions in clinical scores, respiratory rate, and heart rate.
• No significant changes were noted in oxygen saturation or blood gas levels.
• 29.8% required non-invasive ventilation and 26.5% required intubation; younger children and those with bronchiolitis responded less favorably.

Conclusions:

• Heliox therapy demonstrated efficacy in improving clinical parameters for pediatric airway insufficiency.
• A notable proportion of patients, particularly infants and those with bronchiolitis, necessitated further ventilatory support.
• Heliox therapy is a viable option but does not eliminate the need for mechanical ventilation in all critically ill children.